EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

COVID ‐19 and Pregnancy: Key Findings

Gabrielle Gimenes Lima, Ana Flávia Segati, Giovanna Santos Oliveira, Nicoly Simões de Melo, Túlio Nakazato da Cunha, Elizabeth De Gaspari iD

Scandinavian Journal of Immunology · 2026-04 · 103 (4)

DOI: 10.1111/sji.70109 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Scandinavian Journal of Immunology, online erschienen am 25.03.2026. Verfasst von Gabrielle Gimenes Lima und 5 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Center, Adolfo Lutz Institute, São Paulo, Brazil. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Pregnancy Complications, Infectious, COVID-19 Vaccines. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pregnant individuals were prioritised for COVID‐19 research due to concerns about increased susceptibility and limited clinical trial data. This narrative review synthesises evidence on maternal infection, immunological adaptations, placental susceptibility, and antibody transfer following maternal SARS‐CoV‐2 vaccination. Symptomatic COVID‐19 during pregnancy increases risks of severe outcomes, whereas vertical transmission remains rare. Placental pathology is characterised mainly by maternal vascular malperfusion and inflammation, with limited evidence of direct viral infection. Maternal vaccination—particularly with mRNA vaccines—induces robust IgG responses with efficient transplacental and lactational transfer, conferring passive neonatal protection. Key uncertainties include optimal vaccine timing, durability of neonatal immunity, and variant‐specific responses. Strengthening standardised research and ensuring inclusion of pregnant individuals is essential for global maternal health policy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Pregnancy Complications, InfectiousCOVID-19 VaccinesHumansFemalePregnancyPlacentaImmunity, Maternally-AcquiredInfectious Disease Transmission, VerticalAntibodies, ViralVaccination

Stichwörter der Autor:innen

SARS‐CoV‐2immune responseimmunisationpregnancyvaccine

Substanzen

COVID-19 VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • Immunology Center, Adolfo Lutz Institute, São Paulo, Brazil.
  • InterUnit Post-Graduation in Biotechnology, University of São Paulo, São Paulo, Brazil.

ORCID-Profile: Elizabeth De Gaspari

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Lima, G. G., Segati, A. F., Oliveira, G. S., de Melo, N. S., da Cunha, T. N., & De Gaspari, E. (2026). COVID ‐19 and Pregnancy: Key Findings. Scandinavian Journal of Immunology, 103(4). https://doi.org/10.1111/sji.70109

Vancouver

Lima GG, Segati AF, Oliveira GS, de Melo NS, da Cunha TN, De Gaspari E. COVID ‐19 and Pregnancy: Key Findings. Scandinavian Journal of Immunology. 2026;103(4). doi:10.1111/sji.70109

BibTeX
@article{Lima2026,
  author = {Lima, Gabrielle Gimenes and Segati, Ana Flávia and Oliveira, Giovanna Santos and de Melo, Nicoly Simões and da Cunha, Túlio Nakazato and De Gaspari, Elizabeth},
  title = {COVID ‐19 and Pregnancy: Key Findings},
  journal = {Scandinavian Journal of Immunology},
  year = {2026},
  volume = {103},
  number = {4},
  doi = {10.1111/sji.70109}
}
Kostenlos starten →